FOXO3, a Resilience Gene: Impact on Lifespan, Healthspan, and Deathspan

Authors:

Abstract
Oliver Wendell Holmes is purported to have said, “Old age is always fifteen years older than I am.” Given recent rapid advances in understanding the aging process – from molecular, cellular, tissue, organ, to whole body aging – Holmes appears prescient. There is little doubt that people age at different rates and in different ways ( 1). If one could indeed remain 15 to 20 years “biologically younger” than their chronological age and delay the onset of aging-related chronic diseases and disability, that would be quite an achievement for the individual and society ( 2). This, of course, assumes that if lifespan is prolonged, one also compresses morbidity, resulting in a longer healthspan, not a longer “deathspan” (ie, poor quality of life from extra years of severe disease and incapacitation), see Figure 1.
Funding Information
  • Kuakini Medical Center
  • National Institutes of Health (N01-AG-4-2149, 5 U01 AG019349-05, 5R01AG027060, 5R01AG038707)
  • National Heart, Lung, and Blood Institute (N01-HC-05102)

This publication has 40 references indexed in Scilit: